O	0	8	Axillary
O	9	24	lymphadenectomy
O	25	28	for
O	29	35	breast
O	36	42	cancer
O	42	43	.

O	44	45	A
O	46	56	randomized
O	57	67	controlled
O	68	73	trial
O	74	83	comparing
O	84	85	a
B-intervention	86	93	bipolar
I-intervention	94	100	vessel
I-intervention	101	108	sealing
I-intervention	109	115	system
O	116	118	to
O	119	122	the
B-control	123	135	conventional
I-control	136	145	technique
O	145	146	.

O	147	149	To
O	150	157	compare
O	158	164	safety
O	165	168	and
O	169	177	efficacy
O	178	180	of
O	181	182	a
O	183	190	bipolar
O	191	197	vessel
O	198	205	sealing
O	206	212	system
O	213	214	(
O	214	218	BVSS
O	218	219	)
O	220	222	to
O	223	226	the
O	227	239	conventional
O	240	249	technique
O	250	252	in
O	253	261	axillary
O	262	266	node
O	267	277	dissection
O	277	278	.

B-total-participants	279	282	116
B-eligibility	283	288	women
I-eligibility	289	293	with
I-eligibility	294	300	breast
I-eligibility	301	307	cancer
O	308	312	were
O	313	323	randomized
O	324	326	to
O	327	339	conventional
O	340	344	node
O	345	355	dissection
O	356	364	surgical
O	365	374	technique
O	375	376	(
O	376	383	control
O	383	384	;
O	385	386	n
O	387	388	=
B-control-participants	389	391	58
O	391	392	)
O	393	395	by
O	396	403	scalpel
O	404	407	and
O	408	417	monopolar
O	418	425	cautery
O	426	428	or
O	429	434	using
O	435	437	an
O	438	452	electrothermal
O	453	457	BVSS
O	458	459	(
O	459	464	study
O	465	470	group
O	470	471	;
O	472	473	n
O	474	475	=
B-intervention-participants	476	478	58
O	478	479	)
O	479	480	.

O	481	484	The
O	485	491	median
O	492	493	(
O	493	498	range
O	498	499	)
B-outcome	500	505	total
I-outcome	506	512	volume
I-outcome	513	515	of
I-outcome	516	521	fluid
I-outcome	522	531	collected
I-outcome	532	534	by
I-outcome	535	540	drain
I-outcome	541	544	and
I-outcome	545	556	aspirations
O	557	560	was
B-iv-cont-median	561	564	305
O	565	566	(
O	566	568	30
O	568	569	-
O	569	573	1420
O	573	574	)
O	575	577	mL
O	578	580	in
O	581	584	the
O	585	590	study
O	591	596	group
O	597	600	and
B-cv-cont-median	601	604	335
O	605	606	(
O	606	608	80
O	608	609	-
O	609	613	1070
O	613	614	)
O	615	617	mL
O	618	620	in
O	621	624	the
O	625	632	control
O	633	638	group
O	639	640	(
O	640	641	p
O	642	643	=
O	644	645	0
O	645	646	.
O	646	649	325
O	649	650	)
O	650	651	.

O	652	655	The
O	656	662	median
O	663	664	(
O	664	669	range
O	669	670	)
B-outcome	671	676	total
I-outcome	677	683	volume
I-outcome	684	686	of
I-outcome	687	692	lymph
I-outcome	693	702	collected
I-outcome	703	705	by
I-outcome	706	718	percutaneous
I-outcome	719	730	aspirations
O	731	734	was
B-iv-cont-median	735	738	207
I-iv-cont-median	738	739	.
I-iv-cont-median	739	740	5
O	741	742	(
O	742	744	40
O	744	745	-
O	745	749	1050
O	749	750	)
O	751	753	mL
O	754	756	in
O	757	760	the
O	761	766	study
O	767	772	group
O	773	776	and
B-cv-cont-median	777	780	505
O	781	782	(
O	782	785	270
O	785	786	-
O	786	789	705
O	789	790	)
O	791	793	mL
O	794	796	in
O	797	800	the
O	801	808	control
O	809	814	group
O	815	816	(
O	816	817	p
O	818	819	=
O	820	821	0
O	821	822	.
O	822	825	010
O	825	826	)
O	826	827	.

O	828	831	The
B-outcome	832	841	incidence
I-outcome	842	844	of
I-outcome	845	851	seroma
O	852	855	was
O	856	863	similar
O	864	866	in
O	867	871	both
O	872	878	groups
O	879	880	(
O	880	881	p
O	882	883	=
O	884	885	0
O	885	886	.
O	886	889	845
O	889	890	)
O	890	891	.

O	892	895	The
B-outcome	896	904	axillary
I-outcome	905	910	drain
I-outcome	911	914	was
I-outcome	915	922	removed
O	923	930	earlier
O	931	933	in
O	934	937	the
O	938	943	study
O	944	949	group
O	950	954	than
O	955	957	in
O	958	966	controls
O	967	968	(
O	968	969	p
O	970	971	=
O	972	973	0
O	973	974	.
O	974	977	046
O	977	978	)
O	978	979	.

O	980	983	The
O	984	987	use
O	988	990	of
O	991	992	a
O	993	997	BVSS
O	998	1004	offers
O	1005	1013	marginal
O	1014	1024	advantages
O	1025	1029	when
O	1030	1038	compared
O	1039	1041	to
O	1042	1045	the
O	1046	1058	conventional
O	1059	1068	technique
O	1068	1069	.
